Partners4Access is pleased to announce the addition of Jose Luis Betrian to the executive team
Executive team strengthened to drive further launch support for the biotechnology industry. Continued focus is ‘Orphan Drug Solutions’ a partnership approach to ensuring a successful global launch.
Partners4Access, the global access experts for orphan drugs, has strengthened its executive team this week with the addition of Jose Luis Betrian. Jose Luis joins as Executive Director, Business Development. This addition helps further secure P4A’s position as the go-to partner for orphan drug manufacturers. Jose Luis Betrian will be based at the firm’s Global Headquarters in central London.
Schmitz, Managing Partner at P4A said “Jose Luis brings a solid foundation in commercial access success. His wealth of experience and track record in driving access for speciality and orphan drugs over the past 20 years will be used to continue to optimise our clients’ launch success. We are excited about his appointment and look forward to a great future together.” Schmitz added “Recruiting the kind of talent Jose Luis represents is important for continued growth. But we strive for more: we recruit talent that share our company’s vision in offering the best access support for orphan drugs.”
Betrian adds, “I am excited about the future with P4A. The company’s growth and 100% client satisfaction shows we have a strong foundation. I look forward to continuing that excellent track record and driving business to make P4A the number one partner for orphan drug manufacturers.”
Partners4Access is a global consultancy 100% focused on orphan drug access.
The company support the biotechnology and pharmaceutical industry along their launch journey to help secure successful price, reimbursement and access for orphan drugs. Partners4Access has solid partnerships with clients supporting their strategy and operations to effectively ensure launch success.